Skip to main navigation Skip to search Skip to main content

P550 Characterisation of hospitalised patients with ulcerative colitis treated with tofacitinib in the OCTAVE clinical programme for up to 7.8 years

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Crohn's and Colitis
DOIs
Publication statusPublished - 2023

Keywords

  • Tofacitinib
  • Medicine
  • Ulcerative colitis
  • Octave (electronics)
  • Placebo
  • Janus kinase inhibitor
  • Internal medicine
  • Gastroenterology
  • Surgery
  • Disease
  • Rheumatoid arthritis
  • Physics
  • Alternative medicine
  • Pathology
  • Optics

Cite this